ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,450Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 3647

$1.3M Total Retail Price of All Prescriptions

Rank: 113 out of 3647

1,368 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,368 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 1,368 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,606 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,536 1,233 1 1
AMLODIPINE BESYLATE 1,367 1,231 2 2
METOPROLOL TARTRATE 1,217 1,032 3 7
ENALAPRIL MALEATE 945 837 4 35
HYDROCODONE-ACETAMINOPHEN 880 646 S3 5 12
OMEPRAZOLE 821 680 6 3
LEVOTHYROXINE SODIUM 779 624 7 5
FUROSEMIDE 758 624 8 8
TRIAMTERENE-HCTZ 521 487 9 58
METFORMIN HCL 506 428 10 6
ATENOLOL 504 414 11 10
ZOLPIDEM TARTRATE 451 338 12 14
LISINOPRIL 423 355 13 4
LOVASTATIN 390 386 14 21
POTASSIUM CHLORIDE 370 276 15 24
SERTRALINE HCL 360 243 16 27
ATORVASTATIN CALCIUM 350 287 17 13
AZITHROMYCIN 331 278 18 34
WARFARIN SODIUM 295 266 19 15
HYDROCHLOROTHIAZIDE 287 257 20 9
CLOPIDOGREL 273 235 21 26
GEMFIBROZIL 250 203 22 82
NIFEDIPINE ER 249 236 23 67
GABAPENTIN 247 169 24 17
NAPROXEN 235 220 25 70
METOPROLOL SUCCINATE 229 194 26 18
RANITIDINE HCL 227 176 27 29
AMOXICILLIN 221 166 28 133
ALLOPURINOL 220 192 29 37
NEXIUM 217 129 30 44
GLYBURIDE 212 192 R 31 54
PLAVIX 210 183 32 39
LOSARTAN POTASSIUM 193 174 33 11
TRAMADOL HCL 182 159 34 22
SPIRONOLACTONE 181 143 35 77
CIPROFLOXACIN HCL 167 123 36 53
PREDNISONE 167 157 36 43
PANTOPRAZOLE SODIUM 165 125 38 38
DIGOXIN 162 140 39 51
CARBIDOPA-LEVODOPA 161 137 40 127
CARVEDILOL 161 136 40 20
MELOXICAM 159 116 42 33
BENAZEPRIL HCL 154 130 43 71
GLIPIZIDE 146 133 44 41
DILTIAZEM 24HR CD 145 130 45 155
ALENDRONATE SODIUM 144 135 46 23
FLUOXETINE HCL 138 95 47 68
LEVOXYL 137 137 48 125
PROAIR HFA 132 92 49 62
ADVAIR DISKUS 125 88 50 52
CRESTOR 116 84 51 19
CARBAMAZEPINE 110 27 52 308
LEVETIRACETAM 110 28 52 122
LANSOPRAZOLE 109 102 54 116
HYDRALAZINE HCL 108 94 55 81
TRICOR 107 72 56 144
ISOSORBIDE MONONITRATE ER 105 85 57 56
CALCITONIN-SALMON 103 39 58 297
RISPERIDONE 100 45 59 83
SYNTHROID 98 82 60 42
PHENYTOIN SODIUM EXTENDED 98 16 60 199
PRAVASTATIN SODIUM 94 71 62 16
KLOR-CON M20 93 68 63 121
TAMSULOSIN HCL 90 78 64 28
DOXYCYCLINE HYCLATE 88 70 65 145
LEVOFLOXACIN 87 66 66 87
NITROSTAT 86 57 67 206
NITROGLYCERIN PATCH 85 85 68 203
CLONIDINE HCL 85 75 68 46
LANTUS 84 56 70 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 60 70 36
DIOVAN 84 61 70 40
GLIMEPIRIDE 83 81 73 45
PAROXETINE HCL 81 71 74 60
RAMIPRIL 80 38 75 101
BUMETANIDE 78 64 76 134
DOXAZOSIN MESYLATE 75 54 77 57
INSULIN SYRINGE 74 51 78 76
K-TAB 74 74 78 319
ZETIA 74 74 78 96
FLUTICASONE PROPIONATE 73 55 81 32
VERAPAMIL ER 72 69 82 99
SPIRIVA 70 54 83 93
VENTOLIN HFA 70 61 83 88
CLOTRIMAZOLE-BETAMETHASONE 69 42 85 84
TRIAMTERENE-HYDROCHLOROTHIAZID 68 67 86 223
KLOR-CON 10 68 55 86 106
TRAZODONE HCL 68 48 86 64
DONEPEZIL HCL 68 61 86 30
PROPRANOLOL HCL 67 61 90 156
TERAZOSIN HCL 67 66 90 103
OXYBUTYNIN CHLORIDE 63 63 92 107
COMBIVENT 63 36 92 170
VYTORIN 62 62 94 191
PERMETHRIN 61 11 95 429
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 47 96 110
CITALOPRAM HBR 57 39 97 25
CELEBREX 57 45 97 111
DILTIAZEM ER 56 51 99 167
DICLOFENAC SODIUM 56 45 99 86
BACLOFEN 56 0 99 97
LIPITOR 56 42 99 113
CEFUROXIME 56 50 99 228
METRONIDAZOLE 55 32 104 247
SINGULAIR 54 29 105 90
JANTOVEN 54 45 105 140
FENOFIBRATE 53 39 107 50
PRAMIPEXOLE DIHYDROCHLORIDE 52 38 108 307
LAMOTRIGINE 52 14 108 266
ESCITALOPRAM OXALATE 52 45 108 65
LABETALOL HCL 51 47 111 172
FOSINOPRIL SODIUM 50 46 112 241
QUETIAPINE FUMARATE 50 13 112 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.